MindWalk Holdings HYFT
NASDAQ HYFT
$1.33 +0.00 (+0.00%)
As of: Sep 4, 2026 · 2:23 PM EDT

MindWalk Holdings (HYFT) Non-Current Deferred Tax Liability (2020 - 2026)

MindWalk Holdings (HYFT) posted quarterly Non-Current Deferred Tax Liability of $560990.1 for Q2 2026, up 219.32% year-over-year from $175682.2 in Q2 2025, and up 219.32% quarter-over-quarter from $175682.2 in Q2 2025.

Analysis

MindWalk Holdings (HYFT) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $560990.1 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability rose 219.32% year-over-year to $560990.1; the TTM figure through Apr 2026 stood at $560990.1 (up 219.32% YoY), while the FY2026 annual figure was $560990.1, up 212.58% from the prior year.
  • Non-Current Deferred Tax Liability advanced to $560990.1 in Q2 2026 per HYFT's latest filing, from $175682.2 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $6.4 million in Q2 2022 and bottomed at $167653.6 in Q1 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $3.7 million across 5 years, with a median of $5.1 million in 2024.
  • Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability soared 595.25% — and 2025, when it slumped 96.71%.
  • MindWalk Holdings' Non-Current Deferred Tax Liability stood at $5.8 million in 2022, then decreased by 8.88% to $5.3 million in 2023, then slumped by 55.41% to $2.3 million in 2024, then tumbled by 92.52% to $175682.2 in 2025, then jumped by 219.32% to $560990.1 in 2026.
  • Business Quant data shows HYFT's Non-Current Deferred Tax Liability at $560990.1 in Q2 2026, $175682.2 in Q2 2025, and $167653.6 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 MindWalk Holdings 61.69 Mn 53.41 Mn 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 560,990.13
Apr 30, 2025 175,682.17
Jan 31, 2025 167,653.59
Oct 31, 2024 2.35 Mn
Jul 31, 2024 2.47 Mn
Apr 30, 2024 3.00 Mn
Jan 31, 2024 5.09 Mn
Oct 31, 2023 5.27 Mn
Jul 31, 2023 5.45 Mn
Apr 30, 2023 5.66 Mn
Jan 31, 2023 5.92 Mn
Oct 31, 2022 5.78 Mn
Jul 31, 2022 5.88 Mn
Apr 30, 2022 6.40 Mn
Jan 31, 2022 851,708.00
Oct 31, 2021 956,911.64
Jul 31, 2021 1.13 Mn
Apr 30, 2021 1.19 Mn
Jan 31, 2021 1.05 Mn
Oct 31, 2020 1.10 Mn